Brief: Simulations Plus Acquires Pro-Ficiency, Creating One-Of-A-Kind Platform Spanning The Drug Development Continuum
12/06/2024 13:16
June 12 (Reuters) - Simulations Plus Inc SLP.O :
* SIMULATIONS PLUS ACQUIRES PRO-FICIENCY, CREATING
ONE-OF-A-KIND
PLATFORM SPANNING THE DRUG DEVELOPMENT CONTINUUM
* SIMULATIONS PLUS INC: PROPOSED DEAL FOR $100 MILLION IN
CASH
* SIMULATIONS PLUS INC: ACQUISITION EXPECTED TO BE ACCRETIVE
TO
FISCAL 2025 EPS
* SIMULATIONS PLUS INC: TRANSACTION FUNDED FROM EXISTING
CASH AND
INVESTMENT RESOURCES
Source text for Eikon: ID:nBw32Nz9a
Further company coverage: SLP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Simulations Plus
See all newsBrief: Simulations Plus Altaris To Pay $26 Million Termination Fee To Co If Merger Agreement Terminated
NASDAQ RESUMED AT 09:55 AM
Brief: Simulations Plus To Be Acquired By Altaris For Approximately $375 Million
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:55 AM
Simulations Plus Q2 results beat expectations but lowers annual profit forecast on tax rate jump